X
ACHEMA MIDDLE EAST 2026
Pharma Advancement
DDF Summit 2025
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Packaging & Logistic

Envirotainer Welcomes China Southern Airlines as the first mainland China carrier to approve the Releye RLP

Content Team by Content Team
5th August 2021
in Packaging & Logistic, Press Statements
Envirotainer Welcomes China Southern Airlines as the first mainland China carrier to approve the Releye RLP

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Envirotainer, the global market leader in secure cold chain solutions for air transportation of pharmaceuticals, announced that China Southern Airlines has approved the Envirotainer Releye® RLP for usage on their fleet of aircrafts. With this approval, China Southern can now transport the Releye® RLP on their extensive network, increasing the capacity to meet ever growing need for temperature-controlled, high-quality and connected ULD solutions.

The Envirotainer Releye® RLP is a LD11-sized unit with a unique air flow technology for maximum temperature stability in the cargo bay. The RLP-size fits 3-euro pallets (or 2-US pallets) and fills a strategic gap between the larger RAP-size and the smaller RKN-size allowing for increase efficiency by mixing and matching sizes based on shipment volume. The Releye® RLP uses rechargeable batteries to power its electric heating and compressor cooling system and can power its system for over 170 hours on a single charge.

With its unique feature set, the Releye® RLP sets a new standard for secure cold chain solutions bringing a temperature-controlled air freight container to market with a new footprint, industry-leading autonomy and fully integrated live monitoring.

“We are happy to welcome China Southern Airlines as the latest carrier of our newest innovation, the Envirotainer Releye® RLP container,” says Don Harrison, Head of Global Key Accounts, Airlines at Envirotainer. He continued, “We will provide China Southern Airlines with the Releye® RLP container so that they can further broaden their portfolio of high-quality temperature-controlled solutions.”

“We are excited to be the first mainland China carrier to approve the Releye® RLP container.” Says Charlotte Huang, Deputy Director of Sales Department, China Southern Air Logistics, “The Releye® container sets a new standard for secure cold chain transport at a time when Covid-19 vaccine and other temperature-controlled medicines are being shipped around the world. With its advanced technology in long battery life, track and trace device and environmentally-friendly designs, this groundbreaking container will undeniably promote mutual cooperation between Envirotainer and China Southern Airlines in every shipment of temperature-sensitive pharma.”

Previous Post

ACG Films and Foils and Danapak Flexibles A/S enters Strategic Partnership for India

Next Post

CytoSMART introduces new, label-free live-cell microscopy solutions with high image quality

Related Posts

Packaging & Logistic

VarioFill: Rotzinger sets new standards with highly flexible filling and capping platform for OTC products

30th August 2025
Major Depressive Disorder
Americas

AbbVie to Acquire Gilgamesh Pharmaceuticals’ Bretisilocin, a Novel, Investigational Therapy for Major Depressive Disorder, Expanding Psychiatry Pipeline

27th August 2025
Schott-Testing
Press Statements

Carbon Reduced Pharmaceutical Glass: SCHOTT Melting Tank Construction Starts and External Certification for FIOLAX® Pro OCF

11th August 2025
Future Trends Shaping
Packaging & Logistic

Future Trends Shaping Pharma Supply Chain and Logistics

30th July 2025
GSK and Hengrui Pharma
Drug Development

GSK and Hengrui Pharma enter agreements to develop up to 12 innovative medicines across Respiratory, Immunology & Inflammation and Oncology

29th July 2025
Aptar Pharma Bolsters Clinical Trial.
Clinical Trials

Aptar Pharma Bolsters Clinical Trial Capabilities with Strategic Materials Manufacturing Acquisition

24th July 2025
Next Post
CytoSMART introduces new, label-free live-cell microscopy solutions with high image quality

CytoSMART introduces new, label-free live-cell microscopy solutions with high image quality

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In